Literature DB >> 12509949

Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma.

L Kretschmer1, G Altenvoerde, J Meller, M Zutt, M Funke, C Neumann, W Becker.   

Abstract

To date, there are no reliable criteria to identify those patients with melanoma-infiltrated sentinel lymph nodes (SLNs) of the groin who might benefit from an extended lymphadenectomy, including the pelvic lymph nodes. We hypothesised that there are pelvic lymph nodes that receive lymph directly from the primary tumour, thus being at an increased risk for metastasis. In order to determine the frequency of radioactively labelled pelvic lymph nodes and the kinetics of their appearance, we introduce here a combination of dynamic lymphoscintigraphy, single photon emission computed tomography (SPECT) and image fusion of SPECT and pelvic Computed Tomography (CT)-scans. By dynamic lymphoscintigraphy and intraoperative gamma probe detection, superficially located inguinal SLNs (median 2 nodes) could be identified in all of the 51 patients included in this analysis. The histological search for micrometastases was positive in 16 patients (median Breslow thickness of the primary melanoma 2.5 mm). In 29 patients, SPECT and the image fusion technique were additionally performed. Radioactively labelled pelvic lymph nodes were detected in 20 individuals, 6 of them presenting aberrant pelvic SLNs that, on dynamic lymphoscintigraphy, had appeared simultaneously with the superficial SLN(s). Of the 6 patients in whom radioactive pelvic lymph nodes were excised together with the superficial SLN(s), only one had positive superficial SLNs. In this patient, the aberrant pelvic SLN proved to be tumour-positive. In 9 patients, there was no radiotracer uptake in the pelvic lymph nodes at all. Image fusion of SPECT and pelvic CT-scans is an excellent tool to localise exactly the pelvic tumour-draining nodes. The significance of radioactively labelled pelvic lymph nodes for the probability of pelvic metastases should be analysed further.

Entities:  

Mesh:

Year:  2003        PMID: 12509949     DOI: 10.1016/s0959-8049(02)00534-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma.

Authors:  Harri Keski-Säntti; Sorjo Mätzke; Tomi Kauppinen; Jyrki Törnwall; Timo Atula
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-08       Impact factor: 2.503

2.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

Review 3.  A review on the clinical uses of SPECT/CT.

Authors:  Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

4.  The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Authors:  Lutz Kretschmer; Hans Peter Bertsch; Pawel Bardzik; Johannes Meller; Simin Hellriegel; Kai-Martin Thoms; Michael Peter Schön; Carsten Oliver Sahlmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-15       Impact factor: 9.236

Review 5.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

6.  The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients.

Authors:  Kristina Rue Nielsen; Annette H Chakera; Birger Hesse; Richard A Scolyer; Jonathan F Stretch; John F Thompson; Michael B Nielsen; Roger F Uren; Peter S Oturai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-17       Impact factor: 9.236

7.  Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT.

Authors:  H Lerman; U Metser; G Lievshitz; F Sperber; S Shneebaum; E Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

8.  Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.

Authors:  Matthew P Doepker; Maki Yamamoto; Matthew A Applebaum; Nupur U Patel; M Jaime Montilla-Soler; Amod A Sarnaik; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2016-09-22       Impact factor: 5.344

9.  Individualized surgery: gamma-probe-guided lymphadenectomy in patients with clinically enlarged lymph node metastases from melanomas.

Authors:  Lutz Kretschmer; Carsten-Oliver Sahlmann; Pavel Bardzik; Christina Mitteldorf; Hans-Joachim Helms; Johannes Meller; Michael Peter Schön; Hans Peter Bertsch
Journal:  Ann Surg Oncol       Date:  2013-01-12       Impact factor: 5.344

10.  Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT.

Authors:  Otakar Kraft; Martin Havel
Journal:  Mol Imaging Radionucl Ther       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.